Pages that link to "Q46514004"
Jump to navigation
Jump to search
The following pages link to Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial (Q46514004):
Displaying 50 items.
- Behavioral and psychological symptoms of dementia (Q21129432) (← links)
- Donepezil for dementia due to Alzheimer's disease (Q24244938) (← links)
- Treatment guidelines for Alzheimer's disease: redefining perceptions in primary care (Q30443975) (← links)
- A Risk-Benefit Assessment of Dementia Medications: Systematic Review of the Evidence (Q33165693) (← links)
- Pharmacological and Nonpharmacological Treatment for Apathy in Alzheimer Disease : A systematic review across modalities (Q34552380) (← links)
- Donepezil in Alzheimer's disease: From conventional trials to pharmacogenetics (Q34968639) (← links)
- Late-onset cinephilia and compulsive behaviors: harbingers of frontotemporal dementia (Q35251909) (← links)
- Donepezil: an update (Q36808057) (← links)
- Beyond symptomatic therapy: a re-examination of acetylcholinesterase inhibitors in Alzheimer's disease (Q36846711) (← links)
- Present and prospective clinical therapeutic regimens for Alzheimer's disease (Q36876447) (← links)
- Pharmacotherapy of Alzheimer disease (Q37004359) (← links)
- Using baseline cognitive severity for enriching Alzheimer's disease clinical trials: How does Mini-Mental State Examination predict rate of change? (Q37292848) (← links)
- DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT (Q37295359) (← links)
- The Effects of Donepezil on 15-Item Geriatric Depression Scale Structure in Patients with Alzheimer Disease (Q37359969) (← links)
- Diagnosis and treatment of patients with severe Alzheimer's disease (Q37394085) (← links)
- Donepezil in severe Alzheimer's disease (Q37402181) (← links)
- Novel regimens and delivery systems in the pharmacological treatment of Alzheimer's disease (Q37448875) (← links)
- Donepezil in the treatment of patients with Alzheimer's disease (Q37464161) (← links)
- Management of behavioral problems in Alzheimer's disease (Q37680018) (← links)
- The role of dopamine in symptoms and treatment of apathy in Alzheimer's disease. (Q37766266) (← links)
- The pharmacoeconomics of cognitive enhancers in moderate to severe Alzheimer's disease (Q37798794) (← links)
- Cholinesterase inhibitor use in Alzheimer's disease: the EPIFARM-Elderly Project. (Q37857031) (← links)
- Pharmacologists and Alzheimer disease therapy: to boldly go where no scientist has gone before. (Q37910243) (← links)
- Pharmacologic Treatment of Apathy in Dementia (Q37917417) (← links)
- Discontinuation of Acetylcholinesterase Inhibitor Treatment in the Nursing Home (Q37934168) (← links)
- The Efficacy of Licensed-Indication Use of Donepezil and Memantine Monotherapies for Treating Behavioural and Psychological Symptoms of Dementia in Patients with Alzheimer’s Disease: Systematic Review and Meta-Analysis (Q37967728) (← links)
- Recommended measures for the assessment of cognitive and physical performance in older patients with dementia: a systematic review (Q38076109) (← links)
- Role of Donepezil in the Management of Neuropsychiatric Symptoms in Alzheimer's Disease and Dementia with Lewy Bodies (Q38700484) (← links)
- Alzheimer's disease with cerebrovascular disease: current status in the Asia-Pacific region (Q38780332) (← links)
- Pharmacotherapeutic strategies in the treatment of severe Alzheimer's disease (Q38906350) (← links)
- Management of Behavioral and Psychological Symptoms of Dementia (Q39209888) (← links)
- Estimation after subpopulation selection in adaptive seamless trials (Q41027668) (← links)
- Treatment effects between monotherapy of donepezil versus combination with memantine for Alzheimer disease: A meta-analysis (Q41474879) (← links)
- Acetylcholinesterase inhibitors promote angiogenesis in chick chorioallantoic membrane and inhibit apoptosis of endothelial cells (Q41848725) (← links)
- A shift in the paradigm of treatment (Q42419056) (← links)
- Donepezil, an acetylcholinesterase inhibitor against Alzheimer's dementia, promotes angiogenesis in an ischemic hindlimb model (Q43229409) (← links)
- Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial (Q46223001) (← links)
- Treatment of Alzheimer's disease in Brazil: II. Behavioral and psychological symptoms of dementia. (Q47141950) (← links)
- Cost-effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO-AD trial). (Q47163824) (← links)
- Efficacy and Safety of Donepezil in Chinese Patients with Severe Alzheimer's Disease: A Randomized Controlled Trial (Q48326143) (← links)
- Efficacy of a high dosage of donepezil for Alzheimer's disease as examined by single-photon emission computed tomography imaging (Q48369370) (← links)
- Effects of sub-chronic donepezil on brain Abeta and cognition in a mouse model of Alzheimer's disease (Q50738123) (← links)
- Pharmacokinetic Comparison of Orally Disintegrating and Conventional Donepezil Formulations in Healthy Korean Male Subjects: A Single-Dose, Randomized, Open-Label, 2-Sequence, 2-Period Crossover Study (Q51371251) (← links)
- Donepezil in patients with severe Alzheimer's disease: double-blind parallel-group, placebo controlled study (Q51913381) (← links)
- Pharmacological interventions for apathy in Alzheimer's disease. (Q53283588) (← links)
- Cholinesterase inhibitors in late-stage Alzheimer's disease. (Q53379025) (← links)
- Donepezil for dementia due to Alzheimer's disease (Q56423406) (← links)
- Clinical efficacy and safety of donepezil in the treatment of Alzheimer's disease in Chinese patients (Q57815825) (← links)
- A review of clinical treatment considerations of donepezil in severe Alzheimer's disease (Q90604221) (← links)
- Course of Cognitive Functioning in Institutionalized Persons With Moderate to Severe Dementia: Evidence From the Severe Impairment Battery Short Version (Q93235015) (← links)